Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarillion Plc Regulatory News (CLLN)

  • This share is currently suspended. It was suspended at a price of 14.27

Share Price Information for Carillion Plc (CLLN)

Share Price is delayed by 15 minutes
Get Live Data
14.27    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £61.40m
CLLN Live PriceLast checked at - London Stock Exchange

Intraday Carillion Plc Share Chart

Form 8.3 - CARILLION PLC

29 Jul 2014 15:17

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the β€œCode”)

1. KEY INFORMATION

(a) Identity of the person whose positions/dealings Barclays PLC.
are being disclosed:
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose CARILLION PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 28 July 2014
(f) Has the discloser previously disclosed, or are YES:
they today disclosing, under the Code in respect BALFOUR BEATTY PLC
of any other party to this offer?

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORD
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 476,195 0.11% 4,422,148 1.03%
(2) Derivatives (other than
options): 4,179,169 0.97% 273,008 0.06%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
4,655,364 1.08% 4,695,156 1.09%

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other executive options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ORD Purchase 844 3.5840 GBP
ORD Purchase 1,719 3.6159 GBP
ORD Purchase 2,715 3.6048 GBP
ORD Purchase 6,510 3.6114 GBP
ORD Purchase 8,272 3.6045 GBP
ORD Purchase 11,500 3.6034 GBP
ORD Purchase 18,569 3.6030 GBP
ORD Purchase 23,593 3.6026 GBP
ORD Purchase 35,406 3.5992 GBP
ORD Purchase 39,898 3.6056 GBP
ORD Purchase 43,981 3.6024 GBP
ORD Purchase 75,945 3.6057 GBP
ORD Purchase 78,027 3.6071 GBP
ORD Sale 612 3.5954 GBP
ORD Sale 1,438 3.5929 GBP
ORD Sale 1,688 3.5840 GBP
ORD Sale 2,949 3.5900 GBP
ORD Sale 4,186 3.5957 GBP
ORD Sale 12,341 3.6119 GBP
ORD Sale 15,383 3.6020 GBP
ORD Sale 15,395 3.6154 GBP
ORD Sale 17,544 3.6024 GBP
ORD Sale 27,497 3.6000 GBP
ORD Sale 36,212 3.5998 GBP
ORD Sale 57,927 3.6010 GBP
ORD Sale 78,598 3.6012 GBP

(b) Derivatives transactions (other than options)

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
ORD SWAP Long 471 3.6051 GBP
ORD CFD Long 925 3.5925 GBP
ORD SWAP Long 15,395 3.6153 GBP
ORD CFD Long 16,789 3.5994 GBP
ORD CFD Long 19,423 3.6003 GBP
ORD SWAP Long 38,768 3.6035 GBP
ORD SWAP Long 39,125 3.5948 GBP
ORD SWAP Long 50,293 3.6021 GBP
ORD SWAP Long 51,011 3.6030 GBP
ORD SWAP Short 400 3.5920 GBP
ORD SWAP Short 2,400 3.6044 GBP
ORD CFD Short 5,041 3.6473 GBP
ORD CFD Short 2,715 3.6048 GBP
ORD CFD Short 20,674 3.6055 GBP
ORD CFD Short 23,593 3.6026 GBP
ORD SWAP Short 47,884 3.5977 GBP
ORD CFD Short 49,533 3.6077 GBP
ORD CFD Short 52,392 3.6057 GBP
ORD CFD Short 32,769 3.6100 GBP
ORD SWAP Short 83,440 3.6043 GBP

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercising

Class of relevant security Product description

e.g. call option

Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state β€œnone”

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state β€œnone”

NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 29 Jul 2014
Contact name: Rajesh Muthanna
Telephone number: 020 3555 4634

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Copyright Business Wire 2014

Date   Source Headline
13th Jul 20174:30 pmRNSHolding(s) in Company
13th Jul 20174:02 pmRNSHolding(s) in Company
13th Jul 20179:25 amRNSHolding(s) in Company
13th Jul 20179:22 amRNSHolding(s) in Company
10th Jul 20177:00 amRNSDirectorate Change
10th Jul 20177:00 amRNSTrading Statement
6th Jul 20174:58 pmRNSHolding(s) in Company
30th Jun 201711:08 amRNSDirectorate Change
19th Jun 20179:07 amRNSBlock listing Interim Review
16th Jun 20174:25 pmRNSHolding(s) in Company
16th Jun 20174:21 pmRNSHolding(s) in Company
16th Jun 20172:26 pmRNSHolding(s) in Company
15th Jun 20177:20 amRNSHolding(s) in Company
14th Jun 20179:08 amRNSDirector/PDMR Shareholding
13th Jun 20174:53 pmRNSHolding(s) in Company
13th Jun 20172:20 pmRNSDirector/PDMR Shareholding
5th Jun 20172:50 pmRNSHolding(s) in Company
1st Jun 20174:25 pmRNSHolding(s) in Company
30th May 20178:07 amRNSHolding(s) in Company
22nd May 20172:38 pmRNSHolding(s) in Company
22nd May 201711:49 amRNSHolding(s) in Company
18th May 20173:25 pmRNSHolding(s) in Company
17th May 20172:15 pmRNSHolding(s) in Company
16th May 201711:47 amRNSHolding(s) in Company
10th May 20177:38 amRNSDirector/PDMR Shareholding
8th May 20173:53 pmRNSHolding(s) in Company
4th May 20172:32 pmRNSHolding(s) in Company
4th May 201710:55 amRNS2017 AGM Results
4th May 20178:29 amRNSHolding(s) in Company
3rd May 201711:57 amRNSAGM Statement
28th Apr 201712:53 pmRNSDirector Declaration
18th Apr 20179:09 amRNSHolding(s) in Company
18th Apr 20177:30 amRNSDirector/PDMR Shareholding
13th Apr 201711:19 amRNSHolding(s) in Company
12th Apr 20177:00 amRNSCarillion selected as preferred bidder
11th Apr 20174:19 pmRNSDirector/PDMR Shareholding
11th Apr 20174:13 pmRNSDirector/PDMR Shareholding
10th Apr 20177:00 amRNSCarillion JV awarded MoD contract
7th Apr 20174:14 pmRNSHolding(s) in Company
30th Mar 20178:07 amRNSHolding(s) in Company
29th Mar 20175:32 pmRNS2016 Annual Report & Accounts and 2017 AGM Notice
29th Mar 201712:37 pmRNSHolding(s) in Company
28th Mar 201712:25 pmRNSHolding(s) in Company
23rd Mar 20174:01 pmRNSHolding(s) in Company
20th Mar 20177:00 amRNSCarillion awarded £90m DIO contract in Cyprus
16th Mar 20178:28 amRNSHolding(s) in Company
16th Mar 20177:48 amRNSHolding(s) in Company
16th Mar 20177:46 amRNSHolding(s) in Company
14th Mar 20174:06 pmRNSHolding(s) in Company
3rd Mar 20179:25 amRNSJoint Venture awarded £490 million contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.